Obesity News and Research

Latest Obesity News and Research

Existing drug shows promise for treating common liver disease

The University of Barcelona has led a study that suggests using the drug known as pemafibrate to treat liver disease associated with metabolic disorders, the most common liver pathology in the world, which affects one in four people. The drug has long been marketed in Japan for another use: improving blood lipid levels in patients with hyperlipidaemia, a common condition in diabetics. Now, however, it could help address this serious liver disease, which still has no specific treatment.

11 Jul 2024

Aging aggravates liver fibrosis in Down Syndrome, new study finds

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 12, entitled, "Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome."

10 Jul 2024

Repurposing pemafibrate to treat liver disease associated with metabolic disorders

10 Jul 2024

Tirzepatide outperforms semaglutide in weight loss for overweight and obese adults

Tirzepatide leads to significantly greater weight loss than semaglutide in overweight or obese adults, with no significant difference in gastrointestinal adverse effects.

10 Jul 2024

How short-term nighttime carb restriction boosts exercise and burns fat

Dietary modifications, like the sleep-low method, may improve exercise performance by optimizing glycogen storage and fat metabolism. A study in Nutrients shows night-time carbohydrate restriction benefits endurance and weight management.

10 Jul 2024

Researchers receive $2 million in grants to advance studies on age-related cognitive impairment

Two University of Oklahoma researchers have been awarded more than $2 million in grants from the Hevolution Foundation to further their studies on age-related cognitive impairment, with an emphasis on improving "health span," or the number of years a person remains healthy.

9 Jul 2024

Semaglutide linked to increased risk of severe eye condition NAION in new study

Research shows semaglutide users face a significantly higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION) compared to users of other medications for diabetes and obesity.

8 Jul 2024

GLP-1 drugs found to lower cancer risk in diabetes patients

Research finds that GLP-1 receptor agonists significantly reduce the risk of 10 out of 13 obesity-associated cancers in type 2 diabetes patients compared to insulins, but show varied results against metformin.

8 Jul 2024

Semaglutide and very-low calorie diet combo shows superior results in managing type 2 diabetes

A study from the University of Nottingham shows that combining Semaglutide with a very-low calorie diet significantly improves weight loss and glycemic control in type 2 diabetes patients.

8 Jul 2024

Gut Blastocystis linked to good cardiovascular health and lower body fat

In an analysis of more than 50,000 individuals from around the world, carriers of gut Blastocystis, a single-celled organism that has been labeled either a parasite or harmless organism but is commonly found in the digestive system, was linked to indicators of good cardiovascular health and decreased body fat.

8 Jul 2024

Beyond BMI: New framework for obesity diagnosis prioritizes overall health

The system for diagnosing and managing obesity can no longer be about just body mass index (BMI), which is excluding many people who would benefit from obesity treatment.

8 Jul 2024

Discovery of TRPC5 gene's role in obesity and postnatal depression offers hope for new treatments

Scientists have identified a gene which, when missing or impaired, can cause obesity, behavioral problems and, in mothers, postnatal depression. The discovery, reported today in Cell, may have wider implications for the treatment of postnatal depression, with a study in mice suggesting that oxytocin may alleviate symptoms.

8 Jul 2024

Excessive pregnancy weight gain linked to prolonged labor, Japanese study reveals

Researchers found that excessive weight gain during pregnancy significantly increases the risk of prolonged labor in Japanese women, emphasizing the importance of monitoring weight gain to prevent complications.

8 Jul 2024

England sees shifting mortality trends with obesity: Cardiovascular deaths decline, neurological and respiratory deaths rise

Obesity-related mortality rates in England show complex trends between 2004 and 2019. While overall mortality rates among obese individuals declined, the study highlights shifting causes of death, including an increase in neurological and respiratory deaths.

7 Jul 2024

Regulatory and psychological considerations of CGM use in people not living with diabetes

Previous
1
...
23
24
25
26
27
28
29
...
1013
Next

Obesity News and Research

Latest Obesity News and Research

Existing drug shows promise for treating common liver disease

Aging aggravates liver fibrosis in Down Syndrome, new study finds

Repurposing pemafibrate to treat liver disease associated with metabolic disorders

Tirzepatide outperforms semaglutide in weight loss for overweight and obese adults

How short-term nighttime carb restriction boosts exercise and burns fat

Researchers receive $2 million in grants to advance studies on age-related cognitive impairment

Semaglutide linked to increased risk of severe eye condition NAION in new study

GLP-1 drugs found to lower cancer risk in diabetes patients

Semaglutide and very-low calorie diet combo shows superior results in managing type 2 diabetes

Gut Blastocystis linked to good cardiovascular health and lower body fat

Beyond BMI: New framework for obesity diagnosis prioritizes overall health

Discovery of TRPC5 gene's role in obesity and postnatal depression offers hope for new treatments

Excessive pregnancy weight gain linked to prolonged labor, Japanese study reveals

England sees shifting mortality trends with obesity: Cardiovascular deaths decline, neurological and respiratory deaths rise

Regulatory and psychological considerations of CGM use in people not living with diabetes

PCOS linked to higher risk of adverse birth outcomes

Biomarkers of food intake: The key to precision nutrition

More than 1,000 small changes in DNA identified that influence age of first period

Study suggests gastric bypass can reduce cardiovascular disease risk, irrespective of weight loss

Scientists unveil KLF15 transcription factor's role in white fat cells, opening new paths for obesity therapy

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Obesity News and Research

Latest Obesity News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in